Beta Bionics, Inc. (BBNX) Financial Statements
Beta Bionics, Inc. (BBNX) reported trailing twelve-month revenue of $119.0M (up 52.5% year on year) and net income of -$73.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$61.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BBNXBeta Bionics, Inc.Follow BBNX — free
—
Price chart with a free account
- Market cap
- 862.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Revenue | 65.1 | 100.3 | 119.0 | |
| Gross profit | 35.9 | 55.5 | 69.4 | |
| Research & development | 26.2 | 34.8 | 38.9 | |
| Operating income | -45.3 | -71.7 | -83.0 | |
| Pre-tax income | -54.8 | -73.2 | -73.0 | |
| Income tax | — | 0.0 | — | |
| Net income | -54.8 | -73.2 | -73.0 | |
| Diluted EPS ($) | -8.60 | -1.81 | -1.64 | |
| Diluted shares (mn) | 6.4 | 40.5 | — |
USD millions · SEC XBRL
Beta Bionics, Inc. — questions
- What is Beta Bionics, Inc.'s revenue?
- $119.0M over the twelve months to 2026-06-30, up 52.5% year on year, from its 10-Q and 10-K filings.
- What is Beta Bionics, Inc.'s net income?
- -$73.0M over the twelve months to 2026-06-30.
- What is Beta Bionics, Inc.'s free cash flow?
- -$61.4M over the twelve months to 2026-06-30.
- What are Beta Bionics, Inc.'s diluted earnings per share?
- $-1.64 over the twelve months to 2026-06-30.
Every figure on this page comes from Beta Bionics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.